Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission

被引:79
作者
Baeten, JM
Overbaugh, J
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA
关键词
HIV-1; transmission; shedding; infectivity;
D O I
10.2174/1570162033352110
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Methods to reduce sexual transmission of HIV-1 are urgently needed to slow the global HIV-1 epidemic. These methods should include interventions that minimize susceptibility in uninfected populations at risk, as well as interventions that decrease the infectiousness of HIV-1 infected individuals. Surprisingly few interventions to prevent HIV-1 transmission have been targeted at persons who are already infected, although such interventions could have a significant impact on population-wide HIV-1 spread. This review summarizes current knowledge of factors that influence HIV-1 infectiousness, with special attention on the role of genital tract HIV-1 as a surrogate marker of infectiousness. Epidemiologic studies have demonstrated good agreement between factors associated with increased HIV-1 transmission and increased HIV-1 genital tract shedding. Treatment of sexually transmitted diseases and initiation of antiretroviral therapy have been shown to reduce HIV-1 shedding and thus are promising interventions that may reduce HIV-1 transmission. Unresolved issues related to optimal measurement techniques for genital HIV-1, promises and limitations of antiretroviral therapy and vaccines to reduce infectiousness, and other intervention strategies still in development are reviewed.
引用
收藏
页码:69 / 86
页数:18
相关论文
共 197 条
[1]  
AHLGREN DJ, 1990, J ACQ IMMUN DEF SYND, V3, P631
[2]   A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding [J].
Al-Harthi, L ;
Kovacs, A ;
Coombs, RW ;
Reichelderfer, PS ;
Wright, DJ ;
Cohen, MH ;
Cohn, J ;
Cu-Uvin, S ;
Watts, H ;
Lewis, S ;
Beckner, S ;
Landay, A .
AIDS, 2001, 15 (12) :1535-1543
[3]   EFFECTS OF DISEASE STAGE AND ZIDOVUDINE THERAPY ON THE DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN SEMEN [J].
ANDERSON, DJ ;
OBRIEN, TR ;
POLITCH, JA ;
MARTINEZ, A ;
SEAGE, GR ;
PADIAN, N ;
HORSBURGH, CR ;
MAYER, KH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20) :2769-2774
[4]  
ANDERSON R M, 1991
[5]  
[Anonymous], 1992, BMJ, V304, P809
[6]   Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection [J].
Auvert, B ;
Buvé, A ;
Ferry, B ;
Caraël, M ;
Morison, L ;
Lagarde, E ;
Robinson, NJ ;
Kahindo, M ;
Chege, J ;
Rutenberg, N ;
Musonda, R ;
Laourou, M ;
Akam, E .
AIDS, 2001, 15 :S15-S30
[7]   MUCOSAL INFECTION OF NEONATAL RHESUS-MONKEYS WITH CELL-FREE SIV [J].
BABA, TW ;
KOCH, J ;
MITTLER, ES ;
GREENE, M ;
WYAND, M ;
PENNINCK, D ;
RUPRECHT, RM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :351-357
[8]   Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV [J].
Baba, TW ;
Trichel, AM ;
An, L ;
Liska, V ;
Martin, LN ;
MurpheyCorb, M ;
Ruprecht, RM .
SCIENCE, 1996, 272 (5267) :1486-1489
[9]   Vitamin A deficiency and the acute phase response among HIV-1-infected and -uninfected women in Kenya [J].
Baeten, JM ;
McClelland, RS ;
Richardson, BA ;
Bankson, DD ;
Lavreys, L ;
Wener, MH ;
Overbaugh, J ;
Mandaliya, K ;
Ndinya-Achola, JO ;
Bwayo, JJ ;
Kreiss, JK .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (02) :243-249
[10]  
Baeten JM, 2001, J ACQ IMMUN DEF SYND, V26, P360, DOI 10.1097/00126334-200104010-00013